The United States allows the sale of Viagra for women

The drug that helps treat sexual desire in women has received approval from US health managers yesterday (August 18). However, this controversial drug is also warned that it can cause dangerous low blood pressure and be shocked when taken with alcohol.

Addyi - Viagra for women is allowed to be sold in the US

The US Food and Drug Administration (FDA) said the drug Viagra for women would be sold under the brand Addyi. But due to safety issues, only health care professionals and certified pharmacies can sell the drug.

FDA has twice refused to license this drug, Flibanserin (the original name of Addyi), produced by private pharmaceutical company Sprout Pharmaceuticals. The latest FDA decision was made after a panel concluded in June that Viagra female pills should be adopted and come with rigorous control measures to ensure users are fully aware of the Its risks.

This special drug is often called "Viagra for women", although it does not work as well as the famous Pfizer male. In 1998, Viagra for men was licensed for the first time to treat erectile dysfunction.

Flibanserin needs to be taken daily. Unlike Viagra, which affects the blood stream to the genitals, flibanserin affects the brain. It's like SSRI inhibitors, including antidepressants like Prozac.

Initially, Boehringer Ingelheim (Germany) developed flibanserin. But it was rejected by the FDA in 2010 after the advisory council said its benefits were no more than the risks users endured. Later, Sprout bought the drug and changed its name to Addyi, and they carried out other studies and continued to submit licenses. In 2013, the FDA refused again.

The decision to refuse has triggered Sprout's lobbying campaign, supported by a number of feminist groups. They accused the FDA of being sexually biased, because of the previous drug Viagra for men. However, the FDA still strongly denies everything.

Flibanserin is for premenopausal women who lack sexual desire. Women who took the drug during the study increased their 1.0-SSE (sexual satisfaction level) every month. Advocates for this drug claim that the results are significant. However, this drug is cautioned to cause side effects for people with liver problems or drinking alcohol or drugs with CYP3A4 inhibitors.